石蒜碱抑制人前列腺癌细胞恶性表型的作用 研究
Study on the Role of Lycorine in Inhibiting the Malignant Phenotype of Human Prostate Cancer Cells
DOI: 10.12677/acm.2026.1672646, PDF,    科研立项经费支持
作者: 余永晟, 李俊谕, 徐金戈, 张俊文, 周家伟:广州医科大学附属第四医院泌尿外科,广东 广州
关键词: PCa传统中草药石蒜碱多西他赛Prostate Cancer Traditional Chinese Medicine Lycorine Docetaxel
摘要: 目的:旨在探讨传统中草药石蒜活性成分石蒜碱(LYC)对人前列腺癌细胞DU-145的生物活性影响包括抑制肿瘤细胞增殖、迁移及体内成瘤活性。方法:实验设计采用3组方案:空白对照组、LYC 10 μmol/L处理组及LYC 100 μmol/L处理组。DU-145细胞在标准培养条件下生长,各组分别加入相应浓度的LYC进行处理。48小时后,通过显微摄影记录细胞形态,采用CCK-8法评估细胞增殖活性,运用划痕愈合实验测定细胞迁移速率。裸鼠皮下成瘤实验评估与多西他赛(DTX)联用体内抑瘤效果。结果:与空白对照相比,LYC在10 μmol/L和100 μmol/L浓度下均能显著抑制DU-145细胞增殖和克隆形成,且抑制作用呈现剂量依赖性(P < 0.05)。体内实验进一步证实,LYC增强DTX对PCa的治疗作用,有效降低肿瘤在动物模型中的生长能力。结论:LYC与DTX协同干预能有效抑制PCa细胞增殖、迁移以及体内成瘤等恶性生物学行为,提示其在PCa治疗领域具有潜在的应用前景。
Abstract: Objective: The aim of this study is to explore the biological activity of the active component of traditional Chinese medicine, lycorine (LYC), on human prostate cancer cells DU-145, including its effects on inhibiting tumor cell proliferation, migration, and in vivo tumor formation. Methods: The experimental design included three groups: blank control group, LYC 10 μmol/L treatment group, and LYC 100 μmol/L treatment group. DU-145 cells were grown under standard culture conditions, and each group was treated with the corresponding concentration of LYC. After 48 hours, cell morphology was recorded using microscopic photography, cell proliferation activity was evaluated by CCK-8 method, and cell migration rate was determined using scratch wound healing assay. The in vivo tumor formation experiment in nude mice was used to evaluate the in vivo anti-tumor effect in combination with docetaxel (DTX). Results: Compared with the blank control group, LYC at concentrations of 10 μmol/L and 100 μmol/L could significantly inhibit the proliferation and colony formation of DU-145 cells, and the inhibitory effect was dose-dependent (P < 0.05). The in vivo experiments further confirmed that LYC enhanced the therapeutic effect of DTX on prostate cancer, effectively reducing the growth ability of tumors in the animal model. Conclusion: The synergistic intervention of LYC and DTX can effectively inhibit the malignant biological behaviors of prostate cancer cells, such as proliferation, migration, and in vivo tumor formation, suggesting its potential application in the treatment of prostate cancer.
文章引用:余永晟, 李俊谕, 徐金戈, 张俊文, 周家伟. 石蒜碱抑制人前列腺癌细胞恶性表型的作用 研究[J]. 临床医学进展, 2026, 16(7): 1304-1309. https://doi.org/10.12677/acm.2026.1672646

参考文献

[1] Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2022) Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 7-33. [Google Scholar] [CrossRef] [PubMed]
[2] Li, W., Liu, H., Zheng, J., Wang, D., Wang, Z., Hong, M., et al. (2025) Kaempferol Modulates ɑ2M Secretion in Bone Marrow-Derived Macrophages by Downregulating GR/PER1-Mediated Lipid Metabolism to Attenuate the Emotional Stress-Aggravated Metastasis of Prostate Cancer. Journal of Ethnopharmacology, 339, Article 119162. [Google Scholar] [CrossRef] [PubMed]
[3] Cao, Z., Yang, P. and Zhou, Q. (2013) Multiple Biological Functions and Pharmacological Effects of Lycorine. Science China Chemistry, 56, 1382-1391. [Google Scholar] [CrossRef] [PubMed]
[4] Roy, M., Liang, L., Xiao, X., Feng, P., Ye, M. and Liu, J. (2018) Lycorine: A Prospective Natural Lead for Anticancer Drug Discovery. Biomedicine & Pharmacotherapy, 107, 615-624. [Google Scholar] [CrossRef] [PubMed]
[5] Yang, C., Xiang, H., Fu, K., et al. (2022) Lycorine Suppresses Cell Growth and Invasion via Down-Regulation of NEDD4 Ligase in Bladder Cancer. American Journal of Cancer Research, 12, 4708-4720.
[6] Havelek, R., Muthna, D., Tomsik, P., Kralovec, K., Seifrtova, M., Cahlikova, L., et al. (2017) Anticancer Potential of Amaryllidaceae Alkaloids Evaluated by Screening with a Panel of Human Cells, Real-Time Cellular Analysis and Ehrlich Tumor-Bearing Mice. Chemico-Biological Interactions, 275, 121-132. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, W., Yang, J., Chen, Y., Xue, R., Mao, Z., Lu, W., et al. (2021) Lycorine Hydrochloride Suppresses Stress‐Induced Premature Cellular Senescence by Stabilizing the Genome of Human Cells. Aging Cell, 20, e13307. [Google Scholar] [CrossRef] [PubMed]
[8] Qi, J., Meng, M., Liu, J., Song, X., Chen, Y., Liu, Y., et al. (2023) Lycorine Inhibits Pancreatic Cancer Cell Growth and Neovascularization by Inducing Notch1 Degradation and Downregulating Key Vasculogenic Genes. Biochemical Pharmacology, 217, Article 115833. [Google Scholar] [CrossRef] [PubMed]
[9] Roy, M., Liang, L., Xiao, X., Peng, Y., Luo, Y., Zhou, W., et al. (2016) Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma. Theranostics, 6, 2209-2224. [Google Scholar] [CrossRef] [PubMed]
[10] Rizzo, M. (2021) Mechanisms of Docetaxel Resistance in Prostate Cancer: The Key Role Played by MiRNAs. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1875, Article 188481. [Google Scholar] [CrossRef] [PubMed]